 |
The Journal of Neuroscience, September 13, 2006, 26(37):9439-9447; doi:10.1523/JNEUROSCI.1443-06.2006
Previous Article | Next Article 
Development/Plasticity/Repair
Estrogen Receptor Protein Interaction with Phosphatidylinositol 3-Kinase Leads to Activation of Phosphorylated Akt and Extracellular Signal-Regulated Kinase 1/2 in the Same Population of Cortical Neurons: A Unified Mechanism of Estrogen Action
Paolo Mannella1 and
Roberta Diaz Brinton1,2
1Department of Molecular Pharmacology and Toxicology and 2Program in Neuroscience, University of Southern California, Los Angeles, California 90033
Correspondence should be addressed to Dr. Roberta Diaz Brinton, University of Southern California, Pharmaceutical Sciences Center, 1985 Zonal Avenue, Los Angeles, CA 90033. Email: rbrinton{at}usc.edu
17 -Estradiol (E2)-induced neuroprotection is dependent on mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K) signaling cascades. We sought to determine whether E2 neuroprotective mechanisms are mediated by a unified signaling cascade activated by estrogen receptor (ER)PI3K interaction within the same population of neurons or whether E2 activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt are independent signaling events in different neuronal populations. Immunoprecipitation of E2-treated cortical neurons was conducted to determine a proteinprotein interaction between ER and the PI3K regulatory subunit p85. Subsequently, cortical neurons were treated with E2 alone or in presence of MAPK inhibitors or PI3K inhibitors. Results of these analyses indicated a proteinprotein interaction between ER and p85 that was time-dependent and consistent with the temporal profile for generation of Akt (pAkt) and ERK1/2 phosphorylation (pERK1/2). E2-induced phosphorylation of Akt, was first apparent at 10 min and maximal at 30 min. Simultaneously, E2-induced pERK1/2 was first apparent at 510 min and maximal at 30 min. Inhibition of PI3K completely blocked E2 activation of pAkt at 10 and 30 min and blocked E2 activation of ERK1/2 at 10 min, which revealed a PI3K-independent activation of ERK at 30 min. Double immunocytochemical labeling for pERK1/2 and pAkt demonstrated that E2 induced both signaling pathways in the same neurons. These results indicate a unified signaling mechanism for rapid E2 action that leads to the coordinated activation of both pERK1/2 and pAkt in the same population of neurons. Implications of these results for understanding estrogen mechanism of action in neurons and therapeutic development are considered.
Key words: PI3K; MAPK; estrogen receptor; estrogen therapy; estrogen signaling; therapeutic development; Alzheimer's disease; Akt
Received Oct. 15, 2005;
revised July 10, 2006;
accepted July 19, 2006.
Correspondence should be addressed to Dr. Roberta Diaz Brinton, University of Southern California, Pharmaceutical Sciences Center, 1985 Zonal Avenue, Los Angeles, CA 90033. Email: rbrinton{at}usc.edu
This article has been cited by other articles:

|
 |

|
 |
 
E.-S. Y. Lee, Z. Yin, D. Milatovic, H. Jiang, and M. Aschner
Estrogen and Tamoxifen Protect against Mn-Induced Toxicity in Rat Cortical Primary Cultures of Neurons and Astrocytes
Toxicol. Sci.,
July 1, 2009;
110(1):
156 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Tremere, J. K. Jeong, and R. Pinaud
Estradiol Shapes Auditory Processing in the Adult Brain by Regulating Inhibitory Transmission and Plasticity-Associated Gene Expression
J. Neurosci.,
May 6, 2009;
29(18):
5949 - 5963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-D. Wang, F. Yang, W.-D. Chen, X. Huang, L. Lai, B. M. Forman, and W. Huang
Farnesoid X Receptor Protects Liver Cells from Apoptosis Induced by Serum Deprivation in Vitro and Fasting in Vivo
Mol. Endocrinol.,
July 1, 2008;
22(7):
1622 - 1632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Calippe, V. Douin-Echinard, M. Laffargue, H. Laurell, V. Rana-Poussine, B. Pipy, J.-C. Guery, F. Bayard, J.-F. Arnal, and P. Gourdy
Chronic Estradiol Administration In Vivo Promotes the Proinflammatory Response of Macrophages to TLR4 Activation: Involvement of the Phosphatidylinositol 3-Kinase Pathway
J. Immunol.,
June 15, 2008;
180(12):
7980 - 7988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Billon, S. Lehoux, L. Lam Shang Leen, H. Laurell, C. Filipe, V. Benouaich, L. Brouchet, C. Dessy, P. Gourdy, A.-P. Gadeau, et al.
The Estrogen Effects on Endothelial Repair and Mitogen-Activated Protein Kinase Activation Are Abolished in Endothelial Nitric-Oxide (NO) Synthase Knockout Mice, but Not by NO Synthase Inhibition by N-Nitro-L-arginine Methyl Ester
Am. J. Pathol.,
March 1, 2008;
172(3):
830 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Wang, L. Liu, and R. D. Brinton
Estradiol-17 -Induced Human Neural Progenitor Cell Proliferation Is Mediated by an Estrogen Receptor -Phosphorylated Extracellularly Regulated Kinase Pathway
Endocrinology,
January 1, 2008;
149(1):
208 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Nilsen, R. W. Irwin, T. K. Gallaher, and R. D. Brinton
Estradiol In Vivo Regulation of Brain Mitochondrial Proteome
J. Neurosci.,
December 19, 2007;
27(51):
14069 - 14077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Xie, R. Patel, T. Wu, J. Zhu, T. Henry, M. Bhaskarabhatla, R. Samudrala, K. Tus, Y. Gong, H. Zhou, et al.
PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr
Int. Immunol.,
April 1, 2007;
19(4):
509 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Hart, M. A. Snyder, T. Smejkalova, and C. S. Woolley
Estrogen Mobilizes a Subset of Estrogen Receptor-{alpha}-Immunoreactive Vesicles in Inhibitory Presynaptic Boutons in Hippocampal CA1
J. Neurosci.,
February 21, 2007;
27(8):
2102 - 2111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhao, K. O'Neill, and R. D. Brinton
Estrogenic Agonist Activity of ICI 182,780 (Faslodex) in Hippocampal Neurons: Implications for Basic Science Understanding of Estrogen Signaling and Development of Estrogen Modulators with a Dual Therapeutic Profile
J. Pharmacol. Exp. Ther.,
December 1, 2006;
319(3):
1124 - 1132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Morrison, R. D. Brinton, P. J. Schmidt, and A. C. Gore
Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women
J. Neurosci.,
October 11, 2006;
26(41):
10332 - 10348.
[Full Text]
[PDF]
|
 |
|
|